| Veramyst (fluticasone furoate nasal spray) / GSK |
| Completed | 4 | 1000 | US | Fluticasone furoate and fexofenadine | GlaxoSmithKline | Rhinitis, Allergic, Seasonal | 02/07 | 02/07 | | |
NCT00519636: Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS |
|
|
| Completed | 4 | 360 | US | FPNS, fluticasone propionate, fluticasone furoate, FFNS, placebo FFNS, placebo FPNS | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 11/07 | 11/07 | | |
NCT00539006: Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS |
|
|
| Completed | 4 | 377 | US | FPNS, fluticasone propionate, fluticasone furoate, FFNS, placebo FPNS, placebo FFNS | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 11/07 | 11/07 | | |
| Completed | 4 | 680 | US | fluticasone furoate, fexofenadine, fluticasone furoate, fexofenadine | GlaxoSmithKline | Rhinitis, Allergic, Seasonal | 11/07 | 11/07 | | |
NCT00473915: Intranasal Steroids and the Nasal Ocular Response |
|
|
| Completed | 4 | 20 | US | fluticasone furoate | University of Chicago, GlaxoSmithKline | Seasonal Allergic Rhinitis | 12/07 | 02/08 | | |
NCT00609674 / 2007-006562-15: A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis |
|
|
| Completed | 4 | 315 | US, Canada, Europe, RoW | Fluticasone furoate nasal spray, Placebo | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 06/08 | 06/08 | | |
NCT00584987: Intranasal Steroids and Oxymetazoline in Allergic Rhinitis |
|
|
| Completed | 4 | 64 | US | Fluticasone furoate, Veramyst, Placebo Fluticasone furoate, Oxymetazoline, Oxymetazoline hydrochloride, Placebo Oxymetazoline | University of Chicago, GlaxoSmithKline | Allergic Rhinitis | 07/09 | 07/09 | | |
AVY-REG00108VN, NCT01270958: A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis |
|
|
| Completed | 4 | 60 | RoW | Avamys aqueous nasal spray 110mcg | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 02/10 | 02/10 | | |
NCT01007253: Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms |
|
|
| Completed | 4 | 21 | US | PL nasal spray, fluticasone furoate (FF), Veramyst, PL eye drops, olopatadine (OLO), Olopatadine 0.2% ophthalmic solution | University of Chicago, GlaxoSmithKline | Seasonal Allergic Rhinitis | 04/10 | 08/11 | | |
NCT01013701: Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease |
|
|
| Terminated | 4 | 7 | NA | fluticasone furoate, placebo | Johns Hopkins University, GlaxoSmithKline | Patients With Nasal Polyps | 07/10 | 07/10 | | |
NCT00997620: Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis |
|
|
| Completed | 4 | 40 | NA | Fluticasone furoate Nasal Spray 110 mcg, Fluticasone Furoate Nasal Spray, Placebo, Placebo Veramyst Nasal Spray | Western Sky Medical Research, GlaxoSmithKline | Seasonal Allergic Rhinitis | 09/10 | 10/10 | | |
NCT00682643 / 2015-004891-31: A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis |
|
|
| Completed | 4 | 550 | US | fluticasone furoate nasal spray, vehicle placebo nasal spray | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 02/11 | 02/11 | | |
| Completed | 4 | 474 | US, Canada, Europe, RoW | Fluticasone furoate nasal spray, Placebo nasal spray | GlaxoSmithKline | Rhinitis, Allergic, Perennial | 03/11 | 03/11 | | |
